What is Cushing & Rabinovitz?
Cushing & Rabinovitz P.C. operates as a premier provider of periodontal care and advanced dental implant solutions. With a multi-site presence spanning Framingham, Milford, Lexington, and Acton, the practice distinguishes itself through a team of diplomates certified by the American Board of Periodontology. The firm focuses on a collaborative care model, working in tandem with restorative dentists to deliver comprehensive treatment plans that address complex gum disease and tooth replacement needs. Their market position is defined by a commitment to clinical precision and patient-centric environments, effectively bridging the gap between surgical intervention and long-term oral health maintenance.
How much funding has Cushing & Rabinovitz raised?
Cushing & Rabinovitz has raised a total of $301K across 2 funding rounds:
Debt
$150K
Debt
$151K
Debt (2020): $150K with participation from PPP
Debt (2021): $151K led by PPP
Key Investors in Cushing & Rabinovitz
PPP
Public-Private Partnership
What's next for Cushing & Rabinovitz?
With the recent capital deployment, Cushing & Rabinovitz is poised to optimize its service delivery infrastructure. The strategic focus will likely center on enhancing technological integration within their surgical suites and expanding the reach of their specialized periodontal hygiene programs. As the firm navigates this late-stage growth phase, the emphasis remains on maintaining the high standards of care that have established their reputation in the Massachusetts dental market. Future initiatives may include further investment in advanced diagnostic tools and the potential expansion of their collaborative network with regional restorative specialists to capture a larger share of the dental implant market.
See full Cushing & Rabinovitz company page
